KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene

por Roberts, Melyssa S., Anstine, Lindsey J., Finke, Viviane S., Bryson, Benjamin L., Webb, Bryan M., Weber-Bonk, Kristen L., Seachrist, Darcie D., Majmudar, Parth R., Keri, Ruth A.
Publicado 2020

Disruption of CDK7 signaling leads to catastrophic chromosomal instability coupled with a loss of condensin-mediated chromatin compaction

por Piemonte, Katrina M., Webb, Bryan M., Bobbitt, Jessica R., Majmudar, Parth R., Cuellar-Vite, Leslie, Bryson, Benjamin L., Latina, Nicholas C., Seachrist, Darcie D., Keri, Ruth A.
Publicado 2023

Differences in Endothelin B Receptor Isoforms Expression and Function in Breast Cancer Cells

por Halaka, Meena, Hired, Zuhaila A., Rutledge, Grace E., Hedgepath, Carly M., Anderson, Michael P., St. John, Haley, Do, Jessica M., Majmudar, Parth R., Walker, Caleb, Alawawdeh, Asma, Stephen, Hannah M., Reagor, Caleb C., Adereti, Jeanette, Jamison, Kiara, Iglesias, Katherine P., Kirmani, Khadija Z., Conway, Rebecca E.
Publicado 2020